Table 2.
Immunohistochemical staining of ERGIC3 in lung cancer tissues
| Characteristic | ERGIC3− | ERGIC3+ | P-value |
|---|---|---|---|
| Gender |
|
|
0.279 |
| Male |
3/17 (18%)# |
14/17 (82%) |
|
| Female |
1/18 (6%) |
17/18 (94%) |
|
| Age, y |
|
|
/ |
| Median |
55.9 |
53.5 |
|
| Range |
36-76 |
38-71 |
|
| Smoking |
|
|
0.323 |
| No |
1/17 (6%) |
16/17 (94%) |
|
| Yes |
3/18 (17%) |
15/18 (83%) |
|
| Histological type |
|
|
0.014* |
| AC |
0 |
22/22 (100%) |
|
| SCC |
4/13 (31%) |
9/13 (69%) |
|
| TNM stage |
|
|
0.419 |
| I + II |
3/20 (15%) |
17/20 (85%) |
|
| III + IV |
1/15 (7%) |
14/15 (93%) |
|
| Differentiation |
|
|
0.006* |
| Poor |
4/11 (36%) |
7/11 (64%) |
|
| Well or Moderate | 0 | 24/24 (100%) |
Statistical significance was determined by the Fisher’s exact test of chi-square test (two-tailed); #: Number of cases applicable/total number of cases examined (with percent in parenthesis); *: Statistically significant, P < 0.05.
Abbreviations: SCC: squamous cell carcinoma; AC: adenocarcinoma; y: year.